Oral antihypertensive regimens (nifedipine retard, labetalol, and methyldopa) for management of severe hypertension in pregnancy: an open-label, randomised controlled trial - The Lancet

Hypertensive Disorders in Pregnancy and Eclampsia (Chapter 25) - The EBCOG Postgraduate Textbook of Obstetrics & Gynaecology

Oral antihypertensive regimens (nifedipine retard, labetalol, and methyldopa) for management of severe hypertension in pregnancy: an open-label, randomised controlled trial - The Lancet

16 Hypertension by Urvi Trivedi - Issuu

PDF) Oral antihypertensive regimens (nifedipine retard, labetalol, and methyldopa) for management of severe hypertension in pregnancy: an open- label, randomised controlled trial

Comparative maternal outcomes of oral nifedipine and intravenous labetalol for severe hypertension during pregnancy: an open label randomized controlled trial. - Document - Gale Academic OneFile

Effectiveness of nifedipine, labetalol, and

The Lancet, 21 September 2019, Volume 394, Issue 10203, Pages 979-1112

Antihypertensive drug therapy for mild to moderate hypertension during pregnancy - Abalos, E - 2018

Comparative analysis of the effect of two antihypertensive therapy regimens on maternal hemodynamic parameters in early- and late-onset preeclampsia » Obstetrics and Gynecology

Clinical Evaluation of Pinggan Yiqi Yangshen Recipe Combined with Labetalol Hydrochloride and Magnesium Sulfate in the Treatment of PIH

Hypertension in Pregnancy: Diagnosis, Blood Pressure Goals, and Pharmacotherapy: A Scientific Statement From the American Heart Association